Pediatric Cancer Clinical Trials in Philadelphia, Pennsylvania
7 studies are recruiting for pediatric cancer in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Lurbinectedin in FET-Fused Tumors
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.
- Stage
- Phase 1
- Ages
- 10 and older
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 6 in total
- Run by
- Children's Hospital of Philadelphia
-
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
This study will evaluate BCB-276, an investigational B7-H3-targeted Chimeric Antigen Receptor (CAR) T cell therapy, in children and young adults with diffuse intrinsic pontine glioma (DIPG). DIPG is a rare and aggressive brain tumor with limited treatment options. CAR T cell therapy uses a patient'…
- Stage
- Phase 2
- Ages
- 1 to 26
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 6 in total
- Run by
- BrainChild Bio, Inc
-
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…
- Stage
- Phase 2
- Ages
- 2 to 25
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 5 in total
- Run by
- Children's Hospital of Philadelphia
-
Massage Impact on Sleep in Pediatric Oncology
This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).
- Stage
- Not phased
- Ages
- 12 to 21
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 2 in total
- Run by
- Children's Hospital of Philadelphia
-
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…
- Stage
- Not phased
- Ages
- 0 and older
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 9 in total
- Run by
- Children's Hospital of Philadelphia
-
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…
- Stage
- Phase 2
- Ages
- 2 to 99
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 5 in total
- Run by
- Children's Hospital of Philadelphia
-
Childhood Cancer Predisposition Study (CCPS)
The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h…
- Stage
- Not phased
- Ages
- Any age
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 7 in total
- Run by
- Emory University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.